Imagion Biosystems Limited
IBXXF
$0.015
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.78% | -3.80% | 88.73% | 88.46% | 80.39% |
| Total Depreciation and Amortization | -98.89% | -98.89% | -98.72% | -98.67% | -35.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.86% | -111.63% | -166.23% | -172.45% | -9.91% |
| Change in Net Operating Assets | -- | -- | -95.20% | -95.09% | -- |
| Cash from Operations | -1,001.16% | -980.43% | 51.50% | 50.38% | 97.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 449.37% |
| Total Debt Issued | -- | -- | -50.00% | -50.00% | -91.20% |
| Total Debt Repaid | -- | -- | 89.80% | 89.80% | -- |
| Issuance of Common Stock | -- | -- | 58.64% | 58.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 30.51% | 30.51% | -- |
| Cash from Financing | -- | -- | 49.36% | 52.83% | -89.26% |
| Foreign Exchange rate Adjustments | -210.71% | -207.14% | 136.45% | 137.38% | -70.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,217.97% | -1,196.87% | 1,110.16% | 1,133.15% | 103.84% |